The Management Board of Selvita S.A. with its registered office in Krakow (“Issuer”), in connection with current report no. 04/2023 dated April 26th, 2023 informs of conclusion on May 5th, 2023 between Selvita d.o.o. with its registered office in Zagreb, Croatia (“Company”) as the buyer,  and the Municipality of Brdovec as the seller, of an agreement for the purchase of a property in the town of Savski Marof, with an area of 26,901 m2 (“Property”).

The price for the acquisition of the Property by the Company has been set at EUR 550,000.

The acquisition of the Property, located in the immediate vicinity of other companies in the life sciences/pharma sector, aims to secure the possibility of further organic development of the Issuer’s Capital Group in Zagreb through the future construction of its own laboratory infrastructure and is consistent with the announced Strategy of the Selvita Capital Group for the years 2022-2025 published in the current report No. 12/2022 dated March 31st, 2022.

Legal basis: Art. 17.1 of MAR

Representatives of the Issuer:     

  • Mirosława Zydroń – Management Board Member
  • Dariusz Kurdas – Management Board Member